Webinars:

1. An Efficient Synthesis of (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate: A Key Intermediate in the Synthesis of Lamivudine and Emtricitabine

2. An Economical Route to Lamivudine and Emtricitabine Featuring a Novel Strategy for Stereospecific Assembly

The Medicines for All Institute’s (M4ALL’s) mission is to improve access to affordable medicines by reducing the cost of active pharmaceutical ingredients (APIs) and key raw materials which can be major cost drivers in treating infectious diseases in the developing world. In collaboration with the Bill & Melinda Gates Foundation, M4ALL has demonstrated cost-effective processes for APIs, starting materials, and key intermediates for many critical medicines.

In support of M4ALL’s mission, M4ALL will host both webinars to introduce our research on efficient and economical routes to Lamivudine and Emtricitabine on April 7, 2020. Participants may register once for access to both webinars.

M4ALL will release a process development report for in April 2020 upon request.

Registration